Study Ties Antidepressants to Suicide

Study Ties Antidepressants to Suicide

THE WASHINGTON POST February 21, 2005

WASHINGTON -- Adults taking popular antidepressants such as Prozac, Paxil and Zoloft are more than twice as likely to attempt suicide as patients given placebos, according to an analysis of hundreds of clinical trials involving tens of thousands of patients.

The results, published last week in the British Medical Journal, mirror a recent finding of the Food and Drug Administration that the drugs increase suicidal thoughts and behavior among some children and offer support to concerns going back 15 years that the mood-lifting pills have a dark side.

The examination of 702 controlled clinical trials involving 87,650 patients is the most comprehensive look at the subject and is particularly telling because it counted suicide attempts and included patients treated for a variety of conditions, including sexual dysfunction, bulimia, panic disorder and depression.

Experts cautioned, however, that the risks should be balanced against the drugs' benefits. They have been shown to be effective against depression and a host of other disorders in adults, a positive track record largely missing in tests of the drugs on children.

The new study is certain to add to the controversy over the class of drugs known as selective serotonin reuptake inhibitors, or SSRI's.

Since the arrival of Prozac in 1988, these drugs have transformed psychiatry in the United States, even as persistent critics have warned that their benefits were hyped and their risks ignored. A spate of lawsuits in recent years have claimed that the drugs were responsible for violent and suicidal behavior.

New analyses of clinical trials in children last year prompted the FDA to require a prominent black box warning on labels, saying that the medications could increase the risk of suicide. The warning refers only to children but is given to all patients.

American psychiatrists continue to strongly back SSRI drugs. Groups such as the American Psychiatric Association say that fears of drug-induced suicide are vastly exaggerated and that untreated depression carries a far greater risk of suicide.

FDA officials have said they are conducting an independent analysis.

--------------------

Antidepressant Safety Debate May Include Adult Patients

By BENEDICT CAREY New York Times February 18, 2005

The yearlong debate over whether antidepressant drugs increase the risk of suicide in some children may soon widen to include adults, as English and Canadian scientists are reporting findings from three new analyses of suicide risk in people over age 18 who have taken the medications.

The new findings are mixed, and apparently contradictory, and likely to encourage both patient advocates who believe that antidepressants like Prozac have hidden dangers, and manufacturers who insist that the medications are safe, experts said.

One of the reports, an analysis of data on antidepressants from previous studies, found that adults taking the drugs were twice as likely to attempt suicide as those receiving a dummy pill or other treatments, but no more likely to complete the act.

The two other reports found no significant link between the medications and suicide. Suicide attempts occurred in less than 0.5 percent of the more than 200,000 people included in the three studies.

All three papers appeared yesterday in the online version of The British Medical Journal.

"There has been a phenomenal amount of pressure to study this issue in adults," in part because of the debate over the risk in children, said Dr. John Geddes, a professor of epidemiological psychiatry at Oxford University and the co-author of an accompanying editorial in the journal. Dr. Geddes was not involved in the studies and has received research money from drug makers.

"We know a certain amount of negative evidence on these drugs has been suppressed, and the more information we have on them in the public domain, the better to guide clinical practice," he said.

In the early 1990's, a panel of experts convened by the Food and Drug Administration concluded that there was not enough evidence to link drugs like Prozac and Zoloft to increased suicide risk and most psychiatrists say that the drugs are more likely to prevent suicide.

But regulators in the United States and Britain recently issued warnings that the drugs, known as selective serotonin reuptake inhibitors, or S.S.R.I.'s, could raise the risk of suicidal thinking in a small number of children and adolescents. The F.D.A. is scrutinizing suicide attempts by adults reported in drug trials.

The risk is extremely difficult to determine, experts say, in part because suicide attempts are rare.

In one of the new analyses, researchers at the University of Ottawa re-evaluated data from 345 antidepressant trials for depression and other conditions, involving 36,455 men and women. The investigators found 143 total suicide attempts, and found that the rate was twice as high in people who were taking S.S.R.I.'s as it was in those getting placebo pills, or some other form of therapy.

"Many people are on these drugs, which makes the rare risk very important," said Dr. Dean Fergusson of the University of Ottawa, who is a lead author of the study.

Dr. David A. Freedman, a clinical trials expert and statistician at the University of California, Berkeley, who was not involved in any of the studies, said that reviews of this kind are not a very reliable way to determine risks. Moreover, he said, the Ottawa study presumed that all antidepressants affected everyone the same way in terms of suicide risk.

"This is like saying your reaction to Prozac is the same as mine to Zoloft, which we know isn't true," he said. "This assumption exaggerates the significance of their findings."

Dr. Fergusson disagreed, saying the assumption of uniform effect gave a conservative estimate.

In another analysis, also in the British journal, doctors evaluated data from 477 trials involving 40,826 people, which were submitted by drug companies to British regulators for safety review. "We found no evidence that S.S.R.I.'s increased the risk of suicide," and weak evidence that the drugs increased the risk of self harm, the authors concluded.

The third study analyzed case records of 146,095 people prescribed antidepressants for the first time from 1995 to 2001. The researchers found no evidence of increased suicide risk in adults taking S.S.R.I.'s compared with people of the same age and similar histories taking other types of antidepressants.

Given that studies report suicidal behavior in a number of ways, experts are skeptical that reviews of trial data will resolve the issue. "We have machinery to pull diamonds from the earth, but we don't have machinery to pull truth from data in these studies," Dr. Freedman said.

Psychiatrists said the studies were not likely to change how they treat patients: the drugs tend to increase agitation and unusual behavior in the first few weeks after the treatment is started, when patients need to be closely monitored, they said.

Source: New York Times

Source: Washington Post

This 'Mental Health E-News' posting is a service of the New York Ass'n of Psychiatric Rehabilitation Services, a statewide coalition of people who use and/or provide community mental health services dedicated to improving services and social conditions for people with psychiatric disabilities by promoting their recovery, rehabilitation and rights. To join our list, please click on the E-News Subscription button.

Last Updated on 02/22/05 webmaster@namiscc.org

Opinions expressed in this web site do not necessarily reflect the views of NAMI Santa Cruz County, NAMI California or any affiliated organizations. We attempt to present a balanced perspective on issues by presenting multiple viewpoints.

FAIR USE NOTICE: This may contain copyrighted (©) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml If you wish to use copyrighted material for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.